CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | -61.2% | 10,367 | -57.1% | 0.00% | – |
| Q1 2022 | $49,000 | +22.5% | 24,139 | +63.1% | 0.00% | – |
| Q4 2021 | $40,000 | -46.7% | 14,800 | -12.3% | 0.00% | -100.0% |
| Q3 2021 | $75,000 | -84.2% | 16,867 | -79.4% | 0.00% | -80.0% |
| Q2 2021 | $474,000 | -64.3% | 81,723 | -56.8% | 0.01% | -70.6% |
| Q1 2021 | $1,329,000 | +6894.7% | 189,290 | +4737.5% | 0.02% | – |
| Q4 2020 | $19,000 | -87.0% | 3,913 | -84.4% | 0.00% | -100.0% |
| Q3 2020 | $146,000 | -11.5% | 25,028 | +2.4% | 0.00% | -33.3% |
| Q2 2020 | $165,000 | +117.1% | 24,443 | +105.5% | 0.00% | +50.0% |
| Q1 2020 | $76,000 | -93.5% | 11,897 | -96.0% | 0.00% | -91.3% |
| Q3 2019 | $1,167,000 | -45.6% | 296,953 | +105.8% | 0.02% | -41.0% |
| Q2 2019 | $2,145,000 | -12.4% | 144,265 | +46.2% | 0.04% | -50.6% |
| Q1 2019 | $2,450,000 | +1217.2% | 98,705 | +854.8% | 0.08% | +777.8% |
| Q4 2018 | $186,000 | -68.4% | 10,338 | -48.4% | 0.01% | -71.9% |
| Q3 2018 | $589,000 | +93.1% | 20,049 | +246.6% | 0.03% | +77.8% |
| Q1 2018 | $305,000 | +301.3% | 5,784 | +414.6% | 0.02% | +350.0% |
| Q4 2017 | $76,000 | +533.3% | 1,124 | +745.1% | 0.00% | +300.0% |
| Q2 2017 | $12,000 | -99.4% | 133 | -99.4% | 0.00% | -99.0% |
| Q3 2015 | $1,922,000 | -6.5% | 20,900 | -10.6% | 0.10% | -3.0% |
| Q2 2015 | $2,055,000 | +8.4% | 23,382 | -8.5% | 0.10% | +7.5% |
| Q1 2015 | $1,896,000 | +75.2% | 25,547 | +7.1% | 0.09% | +40.9% |
| Q3 2014 | $1,082,000 | -12.0% | 23,864 | -19.6% | 0.07% | -10.8% |
| Q2 2014 | $1,229,000 | – | 29,689 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |